DENYES NANCY 4
4 · aTYR PHARMA INC · Filed Jan 9, 2024
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
DENYES NANCY
General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-05+150,000→ 150,000 totalExercise: $1.50Exp: 2034-01-05→ Common Stock (150,000 underlying)
Holdings
- 12,079
Common Stock
Footnotes (2)
- [F1]Includes 2,500 shares acquired on May 15, 2023 and 2,500 shares acquired on November 15, 2023 under the Company's 2015 Employee Stock Purchase Plan.
- [F2]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.